The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP? Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] Journal article

Title	The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
Author(s)	Ridker PM
Source	Arterioscler Thromb Vasc Biol 2008 Jul; 28(7):1222-4.
MeSH	Anti-Inflammatory Agents Biological Markers C-Reactive Protein Cardiovascular Agents Coronary Disease Humans Incidence Inflammation Practice Guidelines as Topic Risk Assessment Risk Factors Time Factors Up-Regulation
Language	eng
Pub Type(s)	Comment Editorial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
PubMed ID	18565847

Advertise on this site.